New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ZIVO Bioscience, Inc.
ZIVO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

59M

Biotechnology

Next Earning date - 11 Nov 2024

59M

Biotechnology

Next Earning date - 11 Nov 2024

17.60USD
Shape1.16 ( 7.06%)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

-55%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 4, 2024
1W 7.06 % 1M 30.86 % 3M 107.06 % 1Y 184.79 %

Key Metrics

Shape
  • Market Cap

    59.24M


  • Shares Outstanding

    3.37M


  • Share in Float

    1.29M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    17.6


  • Average Volume

    1082


  • Beta

    0.274


  • Range

    0.48-17.99


  • Industry

    Biotechnology


  • Website

    https://www.zivobioscience.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

998.71x

P/S Ratio

-22.71x

P/B Ratio

-0.3

Debt/Equity

-22333.7%

Net Margin

$-5.3

EPS

How ZIVO compares to sector?

P/E Ratio

Relative Strength

Shape

ZIVO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$1.20

Shape57%

2025-EPS

$302K

Shape104%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-1.32
vs -1.68

Q3.22

arrow
arrow

N/A

-1.26
vs -1.26

Q4.22

arrow
arrow

N/A

-1.68
vs NA

Q1.23

arrow
arrow

N/A

NA
vs -2.04

Q2.23

arrow
arrow

N/A

-1.32
vs -1.32

Q3.23

arrow
arrow

N/A

-1.05
vs -1.26

Q4.23

arrow
arrow

N/A

-0.96
vs -1.68

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

N/A

-2.78
vs -1.32

Q3.24

arrow
arrow

N/A

-0.39
vs -1.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

4K  vs NA

Q3.23

arrow
arrow

NA

11.8K  vs NA

Q4.23

arrow
arrow

NA

11.8K  vs NA

Q1.24

arrow
arrow

NA

35.7K  vs NA

Q2.24

arrow
arrow

-100%

NA  vs 4K

Q3.24

arrow
arrow

+493%

70K  vs 11.8K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-131%

-1.31
vs -0.69

Q4.22

arrow
arrow

+24862%

248.62
vs -1.31

Q1.23

arrow
arrow

+113%

1.13
vs 248.62

Q2.23

arrow
arrow

+66%

0.66
vs 1.13

Q3.23

arrow
arrow

+167%

1.67
vs 0.66

Q4.23

arrow
arrow

+87%

0.87
vs 1.67

Q1.24

arrow
arrow

+56%

0.56
vs 0.87

Q2.24

arrow
arrow

+359%

3.59
vs 0.56

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

11

11
vs 12

-8%

Q1.22

arrow
arrow

9

9
vs 11

-18%

Q2.22

arrow
arrow

8

8
vs 9

-11%

Q3.22

arrow
arrow

9

9
vs 8

13%

Q4.22

arrow
arrow

13

13
vs 9

44%

Q1.23

arrow
arrow

12

12
vs 13

-8%

Q2.23

arrow
arrow

11

11
vs 12

-8%

Q3.23

arrow
arrow

11

11
vs 11

NA

Earnings Growth

Latest News